Search Results (48)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| A new paradigm for tumor immune escape: ß-catenin-driven immune exclusion. | Academic Article |
Why?
|
| Immunodominance and tumor escape. | Academic Article |
Why?
|
| Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment. | Academic Article |
Why?
|
| A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target. | Academic Article |
Why?
|
| Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression. | Academic Article |
Why?
|
| Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling. | Academic Article |
Why?
|
| Identifying and overcoming immune resistance mechanisms in the melanoma tumor microenvironment. | Academic Article |
Why?
|
| Impact of oncogenic pathways on evasion of antitumour immune responses. | Academic Article |
Why?
|
| Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. | Academic Article |
Why?
|
| Mechanisms of immune evasion by gliomas. | Academic Article |
Why?
|
| MHC Class II Antigen Presentation by Lymphatic Endothelial Cells in Tumors Promotes Intratumoral Regulatory T cell-Suppressive Functions. | Academic Article |
Why?
|
| Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction. | Academic Article |
Why?
|
| Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. | Academic Article |
Why?
|
| Overcoming immune resistance in the tumor microenvironment by blockade of indoleamine 2,3-dioxygenase and programmed death ligand 1. | Academic Article |
Why?
|
| Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis. | Academic Article |
Why?
|